Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size. - Wikidata - wikimedia - TriplyDB

Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.

Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.

http://www.wikidata.org/entity/Q37430584

about

Parameter trajectory analysis to identify treatment effects of pharmacological interventions A computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolism An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway Clustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapy Nutritional systems biology modeling: from molecular mechanisms to physiology.Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementation.Lipoprotein metabolism indicators improve cardiovascular risk prediction.Diagnostic markers based on a computational model of lipoprotein metabolism A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans In silico modeling of the dynamics of low density lipoprotein composition via a single plasma sample.The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses.Clinical and genetic factors influencing cardiovascular risk in patients with familial hypercholesterolemia

P2860

Q28535030-F658331B-CF1B-413E-86BA-1BB974336D22 Q28538300-EE40F137-0CE5-44DB-BA7E-A58E720F5189 Q28540807-0853EA85-9D18-4936-8F99-4F2732E12F8A Q28728567-3142E31B-2825-431B-96DB-A7059DAC31CE Q30943969-30380FE7-32B0-48F3-A3DA-B1BFB2232D62 Q33927951-B3FD6081-27F6-472D-878E-C4B2AD83F0F2 Q35131179-75EBC218-DB57-421A-AA81-EF2E3BAD60A3 Q35834874-A920D401-2D9A-4443-89F5-5257BD92CEEC Q36387268-E80A2779-CDFB-47B6-95E3-B4383E55C7CA Q36843279-E84DD365-CD9E-491C-9FF3-568539EC652B Q51302240-93B68D61-8153-4922-A96E-EDCBDB00E486 Q57364764-F44B44D9-CC83-457C-8CEF-3F9D2EDFE9DF

P2860

Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.

http://www.wikidata.org/entity/Q37430584

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improved cholesterol phenotype ...... le processes to particle size.

@en

Improved cholesterol phenotype ...... le processes to particle size.

@nl

type

label

Improved cholesterol phenotype ...... le processes to particle size.

@en

Improved cholesterol phenotype ...... le processes to particle size.

@nl

prefLabel

Improved cholesterol phenotype ...... le processes to particle size.

@en

Improved cholesterol phenotype ...... le processes to particle size.

@nl

P1433

Q37430584-5ABE6A01-FD4F-4442-B561-8B8DDC223B0D

P1476

Q37430584-D7D4D2DC-12F9-4B43-93B3-4EBCC151D1ED

P2093

Q37430584-0AA5EFF9-F67F-4AC3-83EB-7AB97BE836D3

Q37430584-209A8D4E-63D4-49F0-967F-731C90926729

Q37430584-40FDDF74-11BF-4F4D-86A9-3D1F8062376C

Q37430584-442E5304-728D-4AC3-B81B-7386128A3E13

Q37430584-4F63FF08-5D88-4F98-89A5-231E85FF7446

Q37430584-5A724436-C2D4-4D63-A32F-F4E4DD559581

Q37430584-843EC9CC-91E3-4303-8E4E-6231107719AB

Q37430584-91F33B8C-7401-4162-AFB9-5368C1B4B6D0

Q37430584-EEA21DBD-EFA6-4E91-BC19-F7D177A66DC0

P2860

Q37430584-07DD653B-5618-45A0-A608-4EE321FA2AC3

Q37430584-0DCE4624-606C-4BF9-A673-AD4540241E03

Q37430584-0DDAE280-F9AE-41F7-9D8D-5E264CF63A54

Q37430584-0E711F03-E921-4843-88CB-A2DD382625B8

Q37430584-0F0D6E63-A2B9-49C0-A8CC-195B17C4ED55

Q37430584-13307964-1EA9-475A-9B4B-4B49C1CF57AD

Q37430584-141E88E9-CFB4-4AEF-84D8-5E7924F514ED

Q37430584-17528E1C-F351-4E7F-ABDC-832766A1B4C6

Q37430584-25DAD15B-C5C1-41EF-AD5D-52CAED11022A

Q37430584-27E411E1-4EEE-4780-803D-14BAA5126E31

P304

Q37430584-6B9A8E29-62D1-4CDA-BB22-FC6527E0120D

P31

Q37430584-BA608D0D-60D3-4263-BF44-C8542C4E1CE4

P356

Q37430584-9B6F725D-9A86-4AD8-B809-03DDE690A565

P433

Q37430584-3AEF2F6A-173D-4B92-9D52-268B63A2F3B5

P478

Q37430584-1192330A-0010-49DF-8009-905B88D5DD51

P50

Q37430584-95A3BAC5-F382-483E-A5C2-2AF7FEE2D8DA

Q37430584-F4E94A53-6ADD-4A0A-A824-5010A28F6E47

P577

Q37430584-D5BB4A7E-48A3-4C80-A5EF-A57E3A52B476

P5875

Q37430584-64259592-D832-4383-B02A-B7BDD3217F46

P698

Q37430584-398FA212-4692-48F9-ACE4-E8E31ACE4AF0

P921

Q37430584-7D276768-7DCB-4989-862C-24AF247C4BF4

P932

Q37430584-4452E989-746B-467A-BD12-D7D7CB025331

P356

JLR.M800354-JLR200

P1433

Journal of Lipid Research

P1476

Improved cholesterol phenotype ...... le processes to particle size.

@en

P2093

Albert A de Graaf

http://www.w3.org/2001/XMLSchema#string

Andreas P Freidig

http://www.w3.org/2001/XMLSchema#string

Ben van Ommen

http://www.w3.org/2001/XMLSchema#string

Daniël B van Schalkwijk

http://www.w3.org/2001/XMLSchema#string

Huub C J Hoefsloot

http://www.w3.org/2001/XMLSchema#string

Jan van der Greef

http://www.w3.org/2001/XMLSchema#string

Kees van Bochove

http://www.w3.org/2001/XMLSchema#string

Niek C A van de Pas

http://www.w3.org/2001/XMLSchema#string

Patrick C N Rensen

http://www.w3.org/2001/XMLSchema#string

P2860

Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein

Hepatic lipase: a marker for cardiovascular disease risk and response to therapy

Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake

Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis

Computational lipidology: predicting lipoprotein density profiles in human blood plasma

GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.

Measuring very low density lipoprotein-triglyceride kinetics in man in vivo: how different the various methods really are.

Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.

Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

P304

2398-2411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M800354-JLR200

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Louis M Havekes

P577

2009-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26282183

http://www.w3.org/2001/XMLSchema#string

P698

19515990

http://www.w3.org/2001/XMLSchema#string

P921

P932

2781312

http://www.w3.org/2001/XMLSchema#string